South African Trial Shows Effectiveness of New ARV Drug

A new antiretroviral drug regimen has been given the go-ahead by the World Health Organisation. Preliminary results from studies that include an ongoing trial in South Africa show that dolutegravir is an effective and well-tolerated antiretroviral drug. The results are important because the Johannesburg trial includes a population representative of the real-world populations being treated for HIV across lower- and middle-income countries.

(File photo)

InFocus

See What Everyone is Watching

Don't Miss

AllAfrica publishes around 600 reports a day from more than 150 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.